| Primary |
| Drug Use For Unknown Indication |
60.0% |
| Hypertension |
40.0% |
|
| Renal Failure |
50.0% |
| Renal Failure Acute |
50.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
56.8% |
| Diabetes Mellitus |
6.3% |
| Cardiomyopathy |
5.8% |
| Hypertension |
4.4% |
| Product Used For Unknown Indication |
4.4% |
| Cardiac Failure |
3.4% |
| Type 2 Diabetes Mellitus |
3.4% |
| Coronary Artery Bypass |
1.9% |
| Atrial Fibrillation |
1.5% |
| Epilepsy |
1.5% |
| Prophylaxis |
1.5% |
| Thrombosis Prophylaxis |
1.5% |
| Anticoagulant Therapy |
1.0% |
| Anxiety |
1.0% |
| Depressive Symptom |
1.0% |
| Endocarditis |
1.0% |
| Erysipelas |
1.0% |
| Hypothyroidism |
1.0% |
| Pneumonia |
1.0% |
| Transient Ischaemic Attack |
1.0% |
|
| Renal Failure Acute |
23.8% |
| Renal Failure |
14.3% |
| Rhabdomyolysis |
7.1% |
| Toxic Skin Eruption |
7.1% |
| Hyponatraemia |
4.8% |
| Retinopathy Of Prematurity |
4.8% |
| Vasculitis |
4.8% |
| Weight Decreased |
4.8% |
| Agranulocytosis |
2.4% |
| Anaemia Haemolytic Autoimmune |
2.4% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
2.4% |
| Eczema |
2.4% |
| Fall |
2.4% |
| Hallucination, Visual |
2.4% |
| Hypotension |
2.4% |
| Interstitial Lung Disease |
2.4% |
| Jaundice Hepatocellular |
2.4% |
| Lichenoid Keratosis |
2.4% |
| Lung Disorder |
2.4% |
| Mitral Valve Incompetence |
2.4% |
|
| Concomitant |
| Drug Use For Unknown Indication |
32.5% |
| Product Used For Unknown Indication |
28.2% |
| Hypertension |
7.9% |
| Multiple Myeloma |
3.3% |
| Type 2 Diabetes Mellitus |
3.3% |
| Diabetes Mellitus |
3.0% |
| Bronchopneumopathy |
2.4% |
| Myocardial Infarction |
2.4% |
| Prophylaxis |
2.4% |
| Cardiac Failure |
1.6% |
| Prophylaxis Against Transplant Rejection |
1.6% |
| Rheumatoid Arthritis |
1.6% |
| Small Cell Lung Cancer |
1.6% |
| High Grade B-cell Lymphoma Burkitt-like Lymphoma |
1.4% |
| Pain |
1.4% |
| Actinic Keratosis |
1.1% |
| Acute Coronary Syndrome |
1.1% |
| Atrial Fibrillation |
1.1% |
| Dyspnoea |
1.1% |
| Heart Disease Congenital |
1.1% |
|
| Renal Failure Acute |
9.3% |
| Septic Shock |
9.3% |
| Vomiting |
9.3% |
| Thrombocytopenia |
7.0% |
| Acute Pulmonary Oedema |
4.7% |
| Angioedema |
4.7% |
| Erythema Multiforme |
4.7% |
| Eyelid Oedema |
4.7% |
| Febrile Bone Marrow Aplasia |
4.7% |
| Heparin-induced Thrombocytopenia |
4.7% |
| Hypercalcaemia |
4.7% |
| Locked-in Syndrome |
4.7% |
| Malaise |
4.7% |
| Pancreatitis Acute |
4.7% |
| Respiratory Failure |
4.7% |
| Thrombosis |
4.7% |
| Acute Generalised Exanthematous Pustulosis |
2.3% |
| Agranulocytosis |
2.3% |
| Aphthous Stomatitis |
2.3% |
| Blindness |
2.3% |
|
| Interacting |
| Premedication |
66.7% |
| Product Used For Unknown Indication |
33.3% |
|
|
